Studies have demonstrated that chemerin/CMKLR1 signaling plays an essential role in the recruitment of CMKLR1expressing cells to sites of localized inflammation or tissue damage and also correlated with development of NAFLD [7–9]. Here, RARRES2 is linked to metabolic dysfunction-associated steatotic liver disease.